Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

4 months ago 109

A Biogen facility in Cambridge, Massachusetts.

Brian Snyder | Reuters

  1. Homepage
  2. Finance
  3. Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

Related

Nike parts ways with Kylian Mbappé, soccer superstar signs with On

Nike parts ways with Kylian Mbappé, soccer superstar signs w...

1 day ago 11
Disney names CTO for the first time as media giant expands tech push

Disney names CTO for the first time as media giant expands t...

1 day ago 14
Auto industry urges Trump to not allow Chinese automakers in U.S. ahead of Xi visit

Auto industry urges Trump to not allow Chinese automakers in...

1 day ago 12
RIGHT SIDEBAR TOP AD

Trending

Popular

Yemen’s Houthis seize strategic Mayun Island in Red Sea

Yemen’s Houthis seize strategic Mayun Island in Red Sea

6 days ago 46
A hidden compound in healthy foods may worsen IBD

A hidden compound in healthy foods may worsen IBD

6 days ago 45
First naval battle between drones takes place in the Black Sea

First naval battle between drones takes place in the Black S...

6 days ago 40
Iran war live: Saudi Arabia and Houthis trade strikes over Bab al-Mandeb

Iran war live: Saudi Arabia and Houthis trade strikes over B...

6 days ago 39
Houthi projectile wounds two, damages mosque in Jazan region, Saudi says

Houthi projectile wounds two, damages mosque in Jazan region...

6 days ago 38
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions · Privacy Policy · DMCA · Cookie Policy · Advertise With Us ·

© Primetweets 2026. All rights are reserved